Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) — Financial Flexibility Index
Shijiazhuang Yiling Pharmaceutical Co Ltd (002603) has a Financial Flexibility Index of 0.15x as of September 2025. Free cash flow of CN¥530.90 Million (operating CF CN¥446.51 Million minus capex CN¥84.38 Million) represents 0% of total liabilities (CN¥3.52 Billion). Check Shijiazhuang Yiling Pharmaceutical Co Lt (002603) strategic investment index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shijiazhuang Yiling Pharmaceutical Co Ltd Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Shijiazhuang Yiling Pharmaceutical Co Ltd across 18 annual periods. See Shijiazhuang Yiling Pharmaceutical Co Lt (002603) liquidity to equity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Shijiazhuang Yiling Pharmaceutical Co Ltd (2008–2025)
Year-by-year free cash flow to debt coverage for Shijiazhuang Yiling Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 002603 company net worth.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.75x | CN¥2.02 Billion | CN¥1.78 Billion | CN¥2.69 Billion | ▲ +159.6% |
| 2024 | 0.29x | CN¥901.40 Million | CN¥611.01 Million | CN¥3.12 Billion | ▲ +243.7% |
| 2023 | 0.08x | CN¥466.29 Million | CN¥155.46 Million | CN¥5.54 Billion | ▼ -87.7% |
| 2022 | 0.68x | CN¥3.70 Billion | CN¥3.49 Billion | CN¥5.41 Billion | ▲ +118.1% |
| 2021 | 0.31x | CN¥1.20 Billion | CN¥528.69 Million | CN¥3.83 Billion | ▼ -70.3% |
| 2020 | 1.06x | CN¥2.73 Billion | CN¥1.59 Billion | CN¥2.58 Billion | ▲ +125.5% |
| 2019 | 0.47x | CN¥523.35 Million | CN¥68.93 Million | CN¥1.12 Billion | ▲ +79.3% |
| 2018 | 0.26x | CN¥259.59 Million | CN¥72.37 Million | CN¥993.56 Million | ▼ -31.3% |
| 2017 | 0.38x | CN¥295.00 Million | CN¥114.65 Million | CN¥775.58 Million | ▼ -65.3% |
| 2016 | 1.10x | CN¥1.01 Billion | CN¥641.45 Million | CN¥925.04 Million | ▲ +58.0% |
| 2015 | 0.69x | CN¥610.31 Million | CN¥131.88 Million | CN¥879.56 Million | ▼ -16.3% |
| 2014 | 0.83x | CN¥556.10 Million | CN¥105.90 Million | CN¥671.19 Million | ▼ -28.8% |
| 2013 | 1.16x | CN¥465.15 Million | CN¥55.32 Million | CN¥399.69 Million | ▲ +1.7% |
| 2012 | 1.14x | CN¥367.02 Million | CN¥70.13 Million | CN¥320.75 Million | ▲ +359.9% |
| 2011 | -0.44x | CN¥-230.59 Million | CN¥-408.49 Million | CN¥523.78 Million | ▼ -151.2% |
| 2010 | 0.86x | CN¥584.74 Million | CN¥299.72 Million | CN¥680.08 Million | ▲ +16.9% |
| 2009 | 0.74x | CN¥528.78 Million | CN¥318.21 Million | CN¥718.89 Million | ▼ -24.4% |
| 2008 | 0.97x | CN¥338.45 Million | CN¥210.18 Million | CN¥347.88 Million | — |